Health
Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales. The Danish pharmaceutical company reported a 30% increase […]
Read More
Abortion rights keep winning on the ballot in conservative states — Florida and Arizona could be next
Organizers celebrate the defeat of Issue 1 during an election night party at the Columbus Fire Fighters Local 67 on Tuesday, Aug. 8, 2023 in Columbus, Ohio. Ohio voters have rejected a proposal that would’ve made it more difficult for voters to amend the state constitution, including one measure set for the November ballot that […]
Read More
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put more […]
Read More
We’re optimistic about this struggling entertainment stock despite an expected weak quarter
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Back-to-back losses Still believe in Disney Eli Lilly keeps going 1. Back-to-back losses U.S. stocks on Wednesday were sinking for the second straight session ahead of this week’s key inflation […]
Read More
Obesity drug Wegovy’s landmark trial result could ‘open up’ health insurance access, analyst says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters LONDON — Popular weight-loss drug Wegovy could be made available under more health insurance schemes, after the results of a late-stage trial pointed to the drug’s efficacy in […]
Read More
Amazon to offer reproductive care to more than 1 million employees through partnership with Maven Clinic
Amazon, the United States’ second-largest employer, will now offer fertility and family planning services to employees through a partnership with Maven Clinic. The free offering will be available to more than 1 million eligible Amazon employees spread across 50 countries outside of the U.S. and Canada. Through this partnership, Amazon employees and their partners in […]
Read More
Ohio voters flock to the polls with abortion rights at stake in GOP-backed rules change
A sign asking Ohioans to vote in support of Issue 1 sits above another sign advocating against abortion rights at an event hosted by Created Equal on Thursday, July 20, 2023, in Cincinnati, Ohio. Patrick Orsagos | AP The people of Ohio on Tuesday are voting on a ballot initiative that would make it significantly […]
Read More
Here’s what is behind the stock market’s selloff and what we’re doing about it
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges Palo Alto slumps 1. Stocks sink U.S. stocks tumbled Tuesday after Moody’s downgraded the credit rating on a slew of small and mid-sized banks, sending […]
Read More
Novavax shares jump after Covid vaccine maker posts surprise quarterly profit
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Shares of Novavax jumped as much as 20% in premarket trading Tuesday after the Covid vaccine maker reported a surprise second-quarter profit. The results come […]
Read More
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion to $33.9 billion, up from a previous forecast of […]
Read More